DDrare: Database of Drug Development for Rare Diseases

告示番号	疾患名（ページ内リンク）	臨床試験数
56	ベーチェット病	1

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00720928 (ClinicalTrials.gov)	July 2008	18/7/2008	Flucinolone Acetonide Implant for Treating Refractory Ocular Behcet's Disease	A Multi-Center, Prospective Single Arm Study to Assess the Efficacy and Safety of RETISERT (Intravitreal Flucinolone Acetonide 0.59mg) in Patients With Refractory Ocular Behcet's Disease	Ocular Behcet's Disease,;Non-Infectious Uveitis;Refractory Uveitis	Drug: flucinolone acetonide	Asan Medical Center	Samsung Medical Center;Seoul National University Hospital;Kyunghee University Medical Center	Recruiting	18 Years	N/A	Both	15	Phase 4	Korea, Republic of

No.

TrialID

Date_
enrollment

Date_
registration

Public_title

Scientific_title

Condition

Intervention

Primary_
sponsor

Secondary_
sponsor

Recruitment_
Status

Inclusion_
agemin

Inclusion_
agemax

Inclusion_
gender

Target_
size

Phase

Countries

NCT00720928
(ClinicalTrials.gov)

July 2008

18/7/2008

Flucinolone Acetonide Implant for Treating Refractory Ocular Behcet's Disease

A Multi-Center, Prospective Single Arm Study to Assess the Efficacy and Safety of RETISERT (Intravitreal Flucinolone Acetonide 0.59mg) in Patients With Refractory Ocular Behcet's Disease

Ocular Behcet's Disease,;Non-Infectious Uveitis;Refractory Uveitis

Drug: flucinolone acetonide

Asan Medical Center

Samsung Medical Center;Seoul National University Hospital;Kyunghee University Medical Center

Recruiting

18 Years

N/A

Both

Phase 4

Korea, Republic of